Other Documents. You hereby acknowledge receipt of and the right to receive a document providing the information required by Rule 428(b)(1) promulgated under the Securities Act, which includes the Plan prospectus. In addition, you acknowledge receipt of the Company’s policy permitting certain individuals to sell shares only during certain “window” periods and the Company’s insider trading policy, in effect from time to time.
ROKU, INC (ROKU) (CIK 0001428439)
Source: SEC EDGAR database • Date: August 10, 2018 • SIC: 4841 • CIK: 4841
ROKU, INC (ROKU) (CIK 0001428439)
Source: SEC EDGAR database • Date: August 5, 2021 • SIC: 4841 • CIK: 4841
ROKU, INC (ROKU) (CIK 0001428439)
Source: SEC EDGAR database • Date: February 26, 2021 • SIC: 4841 • CIK: 4841
ROKU, INC (ROKU) (CIK 0001428439)
Source: SEC EDGAR database • Date: May 7, 2021 • SIC: 4841 • CIK: 4841
ROKU, INC (ROKU) (CIK 0001428439)
Source: SEC EDGAR database • Date: August 9, 2019 • SIC: 4841 • CIK: 4841
Tocagen Inc (FBRX, TOCA) (CIK 0001419041)
Source: SEC EDGAR database • Date: February 27, 2019 • SIC: 2834 • CIK: 2834
Mirum Pharmaceuticals, Inc. (MIRM) (CIK 0001759425)
Source: SEC EDGAR database • Date: May 7, 2020 • SIC: 2834 • CIK: 2834
UroGen Pharma Ltd. (URGN) (CIK 0001668243)
Source: SEC EDGAR database • Date: February 28, 2019 • SIC: 2834 • CIK: 2834
Snap Inc (SNAP) (CIK 0001564408)
Source: SEC EDGAR database • Date: February 4, 2022 • SIC: 7370 • CIK: 7370
ROKU, INC (ROKU) (CIK 0001428439)
Source: SEC EDGAR database • Date: November 6, 2020 • SIC: 4841 • CIK: 4841
Next results